This track will explore the underlying biological mechanisms driving atherosclerosis, including lipid accumulation and inflammatory responses. Emphasis will be placed on novel insights into cellular and molecular pathways that contribute to plaque formation and progression.

This session will focus on the role of endothelial cells in vascular health and disease, highlighting their function in maintaining vascular homeostasis. Discussions will include the impact of endothelial dysfunction on cardiovascular outcomes and potential therapeutic strategies.

This track will examine the relationship between lipid metabolism and cardiovascular disease, emphasizing the role of dyslipidemia in atherosclerosis. Research on novel lipid-lowering therapies and their implications for clinical practice will also be presented.

This session will investigate the role of inflammation in the pathogenesis of cardiovascular diseases, particularly focusing on atherosclerosis. Presentations will cover both basic research and clinical studies that elucidate inflammatory pathways as therapeutic targets.

This track will highlight recent advancements in the diagnosis and management of coronary artery disease, including imaging techniques and interventional strategies. The session aims to foster discussions on personalized medicine approaches in treating this prevalent condition.

This session will showcase cutting-edge research methodologies and technologies in cardiovascular science, including genomics, proteomics, and bioinformatics. Participants will have the opportunity to discuss how these innovations can enhance our understanding of cardiovascular diseases.

This track will address the unique challenges and considerations in diagnosing and managing heart disease in special populations, such as women, the elderly, and individuals with comorbidities. Emphasis will be placed on tailored approaches to improve outcomes in these groups.

This session will focus on the translation of basic research findings into clinical applications for atherosclerosis management. Discussions will include successful case studies and the challenges faced in bridging the gap between laboratory and clinical settings.

This track will explore the impact of lifestyle factors, such as diet, exercise, and smoking cessation, on cardiovascular health and disease prevention. Evidence-based strategies for promoting heart-healthy behaviors will be discussed.

This session will highlight novel therapeutic approaches for cardiovascular diseases, including pharmacological agents and innovative interventional techniques. The potential of gene therapy and regenerative medicine in treating heart disease will also be explored.

This track will provide insights into the global burden of cardiovascular disease, examining disparities in prevalence, treatment, and outcomes across different populations. Discussions will focus on public health strategies and policies aimed at reducing cardiovascular morbidity and mortality worldwide.